Online Only Articles

MB4-2 breakpoint in MMSET combined with del(17p) defines a subset of t(4;14) multiple myeloma with very poor prognosis

Immuno-Hematology, Saint-Louis Hospital, Paris, France;Université Paris Diderot, Sorbonne Paris Cité, Paris, France;INSERM UMR 1126 Institut Universitaire d’Hématologie, Paris, France
Université Paris Diderot, Sorbonne Paris Cité, Paris, France;INSERM UMR 1126 Institut Universitaire d’Hématologie, Paris, France
Biological Hematology, Saint-Louis Hospital, Paris, France
Hematology, Avicenne Hospital, Bobigny, France
Hematology, Avicenne Hospital, Bobigny, France
Hematology, Henri Mondor Hospital, Creteil, France
Hematology, Pitie Salpetriere Hospital, Paris, France
Hematology, Necker Hospital, Paris, France
Hematology, Cochin Hospital, Paris, France
Hematology, Caen Hospital, Paris, France
Biostatistics, Saint-Louis Hospital, Paris, France
Biological Hematology, Purpan Hospital, Toulouse, France
University Hospital, Nantes, France
Immuno-Hematology, Saint-Louis Hospital, Paris, France;Université Paris Diderot, Sorbonne Paris Cité, Paris, France;INSERM UMR 1126 Institut Universitaire d’Hématologie, Paris, France
Biological Hematology, Saint-Louis Hospital, Paris, France
Université Paris Diderot, Sorbonne Paris Cité, Paris, France;INSERM UMR 1126 Institut Universitaire d’Hématologie, Paris, France
Immuno-Hematology, Saint-Louis Hospital, Paris, France;Université Paris Diderot, Sorbonne Paris Cité, Paris, France;INSERM UMR 1126 Institut Universitaire d’Hématologie, Paris, France
Vol. 100 No. 11 (2015): November, 2015 https://doi.org/10.3324/haematol.2015.127001